Treatment for Human Immunodeficiency Virus Infection

Phase-Based Progress Estimates
Institute for Sexual and Gender Minority Health and Wellbeing, Chicago, ILHuman Immunodeficiency Virus Infection+1 More
What conditions do you have?

Study Summary

This trial aims to understand experiences unique to transgender men who have sex with men and how they affect HIV risk.

Eligible Conditions
  • Human Immunodeficiency Virus (HIV) Infection
  • Transgender

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: up to 9 months

up to 9 months
Post-hoc thematic analysis across five domains

Trial Safety

Trial Design

0 Treatment Group

30 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 9 months

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,477 Previous Clinical Trials
811,027 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You were identified as a girl when you were born.
You identify as a trans man or transmasculine.
You can use the Internet.
You identify as something other than heterosexual.